Targeting galectin-12 is interesting as it is fat tissue specific and therefore targeting it could help in the prevention/treatment of obesity and diabetes in a targeted manner where other processes, such as cancer, maybe are not affected. This evidence concerns the gene LGALS12 and diabetes mellitus.